Table 1 Demographic data and vascular risk factors in nasopharyngeal carcinoma patients and normal controls
NPC Patients (n = 105) | Controls (n = 25) | p value | |
|---|---|---|---|
Age, y | 52.43 ± 10.23 | 50.68 ± 11.49 | 0.280 |
Gender (female; male) | 33; 72 | 9; 16 | 0.660 |
Body mass index, kg/m 2 | 23.78 ± 3.61 | 22.61 ± 2.95 | 0.142 |
Median (IQR)duration after radiotherapy (months) | 48 (31, 77) | --- | |
Right CCA IMT, mm | 1.025 ± 0.611 | 0.612 ± 0.074 | <0.001 |
Left CCA IMT, mm | 1.036 ± 0.541 | 0.643 ± 0.111 | <0.001 |
Mean CCA IMT, mm | 1.031 ± 0.539 | 0.634 ± 0.111 | <0.001 |
Cholesterol, mg/dL | |||
Total | 201.96 ± 37.52 | 187.17 ± 24.28 | 0.021 |
HDL-C | 61.07 ± 15.23 | 67.62 ± 14.55 | 0.059 |
LDL-C | 118.22 ± 35.06 | 102.13 ± 18.39 | 0.003 |
Triglyceride, mg/dL | 114.39 ± 63.82 | 86.83 ± 35.74 | 0.006 |
Glucose, mg/dL | 90.96 ±14.03 | 86.79 ± 8.12 | 0.165 |
HBA1c | 5.70 ± 0.47 | 5.56 ± 0.23 | 0.146 |
hs-CRP, mg/L | 3.50 ± 1.38 | 1.12 ± 1.00 | <0.001 |
WBC counts (X10 3 /mL) | 4.86 ± 1.62 | 5.32 ± 1.02 | 0.189 |
RBC counts (X10 6 /ml) | 4.61 ± 0.67 | 4.95 ± 0.49 | 0.035 |
Platelet counts (X10 3 /mL) | 225.74 ± 64.74 | 207.75 ± 39.44 | 0.195 |